UPDATE 1-Alexza's agitation drug gets FDA approval

Dec 21 (Reuters) - Alexza Pharmaceuticals Inc said
the U.S. health regulators approved Adasuve, making it the first
treatment for schizophrenia and bipolar disorder that can be
inhaled.

maryland mesothelioma lawyers